These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 36156003)

  • 41. Multi-Omics Perspective Reveals the Different Patterns of Tumor Immune Microenvironment Based on Programmed Death Ligand 1 (PD-L1) Expression and Predictor of Responses to Immune Checkpoint Blockade across Pan-Cancer.
    Huang K; Hu M; Chen J; Wei J; Qin J; Lin S; Du H
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34068143
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pan-cancer landscape of T-cell exhaustion heterogeneity within the tumor microenvironment revealed a progressive roadmap of hierarchical dysfunction associated with prognosis and therapeutic efficacy.
    Zhang Z; Chen L; Chen H; Zhao J; Li K; Sun J; Zhou M
    EBioMedicine; 2022 Sep; 83():104207. PubMed ID: 35961204
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Frontiers in cancer immunotherapy-a symposium report.
    Cable J; Greenbaum B; Pe'er D; Bollard CM; Bruni S; Griffin ME; Allison JP; Wu CJ; Subudhi SK; Mardis ER; Brentjens R; Sosman JA; Cemerski S; Zavitsanou AM; Proia T; Egeblad M; Nolan G; Goswami S; Spranger S; Mackall CL
    Ann N Y Acad Sci; 2021 Apr; 1489(1):30-47. PubMed ID: 33184911
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Emerging role of immunotherapy in urothelial carcinoma-Immunobiology/biomarkers.
    Sweis RF; Galsky MD
    Urol Oncol; 2016 Dec; 34(12):556-565. PubMed ID: 27836246
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A single-cell tumor immune atlas for precision oncology.
    Nieto P; Elosua-Bayes M; Trincado JL; Marchese D; Massoni-Badosa R; Salvany M; Henriques A; Nieto J; Aguilar-Fernández S; Mereu E; Moutinho C; Ruiz S; Lorden P; Chin VT; Kaczorowski D; Chan CL; Gallagher R; Chou A; Planas-Rigol E; Rubio-Perez C; Gut I; Piulats JM; Seoane J; Powell JE; Batlle E; Heyn H
    Genome Res; 2021 Oct; 31(10):1913-1926. PubMed ID: 34548323
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cancer Immunotherapy Targets Based on Understanding the T Cell-Inflamed Versus Non-T Cell-Inflamed Tumor Microenvironment.
    Gajewski TF; Corrales L; Williams J; Horton B; Sivan A; Spranger S
    Adv Exp Med Biol; 2017; 1036():19-31. PubMed ID: 29275462
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Capturing Tumor Heterogeneity and Clonal Evolution by Circulating Tumor DNA Profiling.
    Scherer F
    Recent Results Cancer Res; 2020; 215():213-230. PubMed ID: 31605231
    [TBL] [Abstract][Full Text] [Related]  

  • 48. MEK1/2 inhibition transiently alters the tumor immune microenvironment to enhance immunotherapy efficacy against head and neck cancer.
    Prasad M; Zorea J; Jagadeeshan S; Shnerb AB; Mathukkada S; Bouaoud J; Michon L; Novoplansky O; Badarni M; Cohen L; Yegodayev KM; Tzadok S; Rotblat B; Brezina L; Mock A; Karabajakian A; Fayette J; Cohen I; Cooks T; Allon I; Dimitstein O; Joshua B; Kong D; Voronov E; Scaltriti M; Carmi Y; Conde-Lopez C; Hess J; Kurth I; Morris LGT; Saintigny P; Elkabets M
    J Immunother Cancer; 2022 Mar; 10(3):. PubMed ID: 35292516
    [TBL] [Abstract][Full Text] [Related]  

  • 49. T cell receptor repertoire usage in cancer as a surrogate marker for immune responses.
    Schrama D; Ritter C; Becker JC
    Semin Immunopathol; 2017 Apr; 39(3):255-268. PubMed ID: 28074285
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Targeting novel inhibitory receptors in cancer immunotherapy.
    Ding QQ; Chauvin JM; Zarour HM
    Semin Immunol; 2020 Jun; 49():101436. PubMed ID: 33288379
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cancer Clonal Theory, Immune Escape, and Their Evolving Roles in Cancer Multi-Agent Therapeutics.
    Messerschmidt JL; Bhattacharya P; Messerschmidt GL
    Curr Oncol Rep; 2017 Aug; 19(10):66. PubMed ID: 28803390
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Status of Immune Oncology: Challenges and Opportunities.
    Cesano A; Marincola FM; Thurin M
    Methods Mol Biol; 2020; 2055():3-21. PubMed ID: 31502145
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Enigmas in tumor resistance to kinase inhibitors and calculation of the drug resistance index for cancer (DRIC).
    Smith CIE
    Semin Cancer Biol; 2017 Aug; 45():36-49. PubMed ID: 27865897
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immune Landscape in Tumor Microenvironment: Implications for Biomarker Development and Immunotherapy.
    Pérez-Romero K; Rodríguez RM; Amedei A; Barceló-Coblijn G; Lopez DH
    Int J Mol Sci; 2020 Aug; 21(15):. PubMed ID: 32752264
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Large-Scale Single-Cell and Bulk Sequencing Analyses Reveal the Prognostic Value and Immune Aspects of CD147 in Pan-Cancer.
    Zhang J; Wang Z; Zhang X; Dai Z; Zhi-Peng W; Yu J; Peng Y; Wu W; Zhang N; Luo P; Zhang J; Liu Z; Feng S; Zhang H; Cheng Q
    Front Immunol; 2022; 13():810471. PubMed ID: 35464411
    [TBL] [Abstract][Full Text] [Related]  

  • 56. RNA sequencing: new technologies and applications in cancer research.
    Hong M; Tao S; Zhang L; Diao LT; Huang X; Huang S; Xie SJ; Xiao ZD; Zhang H
    J Hematol Oncol; 2020 Dec; 13(1):166. PubMed ID: 33276803
    [TBL] [Abstract][Full Text] [Related]  

  • 57. clevRvis: visualization techniques for clonal evolution.
    Sandmann S; Inserte C; Varghese J
    Gigascience; 2022 Dec; 12():. PubMed ID: 37039116
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Sclonal architectures predict clinical outcome in colon adenocarcinoma.
    Lv J; Yan L; Lu Y; Liu D; Niu J; Yin L
    J Cell Mol Med; 2021 Feb; 25(3):1796-1800. PubMed ID: 33369051
    [No Abstract]   [Full Text] [Related]  

  • 59. Characterizing neoantigens for personalized cancer immunotherapy.
    Capietto AH; Jhunjhunwala S; Delamarre L
    Curr Opin Immunol; 2017 Jun; 46():58-65. PubMed ID: 28478383
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Novel insights into the disease dynamics of B-cell lymphomas in the Genomics Era.
    Chan FC; Lim E; Kridel R; Steidl C
    J Pathol; 2018 Apr; 244(5):598-609. PubMed ID: 29359812
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.